How the current price of adalimumab fluctuates in the market

The market price of Adalimumab (Adalimumab) has shown a significant fluctuation trend due to the impact of multiple factors such as medical insurance policies, generic drug competition, and the expiration of the original drug patent. In the Chinese market, the original drug Humira has been included in the national medical insurance catalog at an early stage. Its indications include rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, etc. After medical insurance negotiations, the price dropped significantly. At present, the price of the original version in 40mg/0.4ml

At the same time, the launch of domestic generic adalimumab drugs has further promoted price diversification. At present, there are multiple generic versions on the domestic market. These generic drugs have been certified in terms of drug structure, bioequivalence and clinical effects. They are basically the same as the original drugs, but the pricing is obviously more friendly to the people. Usually, the market price of one drug is between 400 to 800 yuan. After being covered by medical insurance, some areas can even control the monthly treatment cost of patients within a few hundred yuan.

In overseas markets, the price of adalimumab’s original drug is still at a high level. In the United States, patients without insurance plans may have to pay hundreds of dollars or more per dose, while in regions such as Europe and Japan, prices vary depending on local health insurance systems and are generally higher than domestic prices. In addition, some low-income countries have also opened up generic drugs, such as India and Bangladesh. The price of generic versions of adalimumab in these regions is lower, about a few hundred yuan per tube. However, due to differences in channel supervision, storage and transportation conditions, the safety and efficacy guarantees are still difficult to compare with those of regularly marketed drugs.

Reference materials:https://www.drugs.com/adalimumab.html